The cultural landscape surrounding body image is undergoing a significant shift, fueled by the rising popularity of GLP-1 medications—originally developed for Type 2 diabetes—and a renewed emphasis on thinness in media and celebrity culture. While these drugs offer potential health benefits, their widespread use and visibility are raising concerns among mental health professionals and body positivity advocates, who fear a rollback of hard-won progress toward body acceptance. The conversation surrounding body image, and the accessibility of tools to alter it, is becoming increasingly complex, raising questions about equity, health, and societal pressures.
For decades, the dominant ideal of beauty has fluctuated, but a consistent thread of thinness has often prevailed. The early 2000s saw a pushback against the “heroin chic” aesthetic of the 1990s, with the emergence of more diverse representation in advertising and entertainment. Brands like Aerie, for example, gained recognition for featuring models of various sizes, as reported by TIME in 2015. However, this movement now appears to be facing headwinds, as a recent wave of emphasis on weight loss gains momentum.
A Pendulum Swinging Back?
The current shift is driven, in part, by the increased accessibility of GLP-1 receptor agonists like Ozempic and Wegovy. Initially prescribed for managing Type 2 diabetes, these medications have gained notoriety for their weight-loss effects. Celebrities openly discussing their use of these drugs, and visibly slimming down have further amplified the trend. This visibility, coupled with the rise of platforms like TikTok and the now-banned hashtag “SkinnyTok,” which promoted extreme dieting and thinness, is creating a potentially harmful environment, according to experts.
Cassandra Cavallaro, a content creator focused on movement for wellness, described the “SkinnyTok” phenomenon as deeply concerning. “It sent a really concerning message that bodies are now becoming a trend again,” she said, emphasizing, “Real people’s bodies aren’t a trend.” The now-banned hashtag, as reported by NPR, highlighted the dangers of equating body size with worth and fueled unrealistic expectations.
Actress Jameela Jamil has also voiced her concerns, stating in a recent video that the current focus on weight loss in Hollywood feels like a step backward. “We fought the system [with body positivity], and now we require to reach back and do that again,” she said, acknowledging the need to re-engage in the fight for body acceptance.
The Two-Tiered Reality of Body Image
Beyond the cultural impact, the accessibility of GLP-1s is also raising questions of equity. Dr. Nafees Alam, a social work professor at Yeshiva University, points out that the proliferation of these drugs exacerbates existing societal inequalities. “The proliferation of drugs widens a two-tiered societal split between those who can afford medical intervention and those who have to ‘settle’ for body positivity,” he explained. He further noted that “Health has been a privilege for those who are socioeconomically affluent for a very long time,” highlighting the systemic barriers to health and wellness that disproportionately affect marginalized communities.
The financial burden of these medications is substantial. Wegovy, for example, can cost over $1,300 per month without insurance, according to Axios, making it inaccessible to many who might benefit from its therapeutic effects. This disparity creates a situation where those with financial resources have access to a tool for altering their bodies, while others are left to navigate a society that often stigmatizes larger bodies.
The Psychological Impact and the Core of Body Positivity
The shift towards prioritizing thinness is also taking a toll on mental health. Katelyn Baker, a clinical psychologist who shares body positivity content on TikTok as @thatfatdoctor, expressed her dismay. “It absolutely feels like backtracking,” she said. “It hurts my heart because of all the work that I personally poured in, as well as all my friends and my colleagues and people who came before me. They’re kind of disappearing.”
Zoë Bisbing, a psychotherapist and founder of Body-Positive Therapy NYC, emphasizes the importance of diverse representation for mental well-being. “Our brains must observe evidence of body diversity,” she explained. “If we don’t, our brains clock our bodies as wrong.” This underscores the importance of challenging narrow beauty standards and promoting acceptance of all body types.
While GLP-1s can offer health benefits beyond weight loss, including potential reductions in the risk of neurological issues and sleep apnea, as reported by Axios, experts caution against framing them solely as a means to achieve a specific body size. Samhita Mukhopadhyay, a writer at The Cut, told NPR that the focus on celebrity use obscures the drugs’ true value and potential risks.
Cavallaro doesn’t view GLP-1 drugs as inherently negative, but she worries about the broader message they send. “The visibility of the weight-loss craze…brings up all this comparison and second-guessing of our bodies, especially for people who were starting to maybe sense OK…Now they’re questioning, should I be doing more? Should I be smaller?”
A Movement Rooted in Social Justice
The body positivity movement, with its origins in the fat acceptance movement of the 1960s, as detailed by TIME, is fundamentally about social justice. It’s not simply about loving your body as it is, but about recognizing that everyone has the right to exist and be treated with respect, regardless of their size or shape. Bisbing clarifies, “It’s not you must love your body as you are. It’s saying, ‘Whoever you are, you have a right to love your body.’”
The conversation surrounding GLP-1s and body image is ongoing, and the long-term effects remain to be seen. The Food and Drug Administration continues to monitor the safety and efficacy of these medications, and further research is needed to fully understand their impact on both physical and mental health. The next key development will be the release of updated guidelines from the American Society of Metabolic and Bariatric Surgery regarding the appropriate use of GLP-1s, expected in early 2026.
What are your thoughts on the impact of GLP-1 medications and changing beauty standards? Share your perspective in the comments below.
